Inhibitory effect of hederagenin on Streptococcus pneumoniae pneumolysin in vitro

Rui Ding1, Yan Zhang2, Xiangzhu Xu1

  • 1Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China.

Microbes and Infection
|September 21, 2021
PubMed

Insights

Hederagenin shows potential in inhibiting pneumolysin (PLY), a key virulence factor of Streptococcus pneumoniae. This natural compound offers a promising new strategy for treating pneumococcal diseases like pneumonia and meningitis.

Area of Science:

  • Microbiology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Streptococcus pneumoniae causes severe infections including pneumonia, meningitis, and bacteremia.
  • Pneumolysin (PLY) is a major virulence factor of S. pneumoniae, contributing to cell damage and inflammation.
  • Targeting PLY offers a potential therapeutic strategy for pneumococcal infections.

Purpose of the Study:

  • To investigate the in vitro inhibitory effects of the natural compound hederagenin on pneumolysin (PLY).
  • To evaluate the potential of hederagenin as a novel therapeutic agent against S. pneumoniae infections.

Main Methods:

  • In vitro analysis of hederagenin's inhibitory activity against purified pneumolysin.
  • Assessment of pneumolysin's biological functions in the presence of hederagenin.

Main Results:

  • Hederagenin demonstrated significant inhibitory effects on pneumolysin activity in vitro.
  • The compound showed potential in mitigating PLY-induced cellular damage and inflammation.

Conclusions:

  • Hederagenin is a promising natural compound for developing new treatments against pneumococcal diseases.
  • Targeting pneumolysin with hederagenin represents a viable therapeutic strategy for S. pneumoniae infections.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...